Lilly

Lilly, Incyte: Olumiant Superior to Placebo in Scalp Hair Regrowth as Early as 24 Weeks
Marketwatch
Fri, 10/1/21 - 10:51 am
Lilly
Incyte
clinial trials
olumiant
alopecia areata
Eli Lilly to reduce list price of Insulin Lispro injection by an additional 40% from Jan. 1, restoring it to 2008 levels
Marketwatch
Tue, 09/28/21 - 11:23 pm
Lilly
insulin
diabetes
Insulin Lispro
drug pricing
Lilly drives more access to COVID-19 antibodies with new infusion centers
Fierce Pharma
Mon, 02/1/21 - 11:31 pm
Lilly
COVID-19
monoclonal antibodies
Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO
Reuters
Fri, 01/17/20 - 12:12 pm
Lilly
M&A
JPMHC 2020
NICE spurns Lilly’s breast cancer drug Verzenio in favor of rivals from Pfizer and Novartisspir
Fierce Pharma
Sat, 10/20/18 - 10:37 pm
Lilly
Verzenio
breast cancer
Pfizer
Ibrance
Novartis
Kisqali
NICE
The Most Likely Incyte Acquisition Deal for 2017?
Motley Fool
Sat, 12/24/16 - 12:11 pm
M&A
Incyte
Gilead Sciences
Lilly
Novartis
Agenus
Lilly releases Phase II results for monoclonal antibody ramucirumab
The Fly on the Wall
Mon, 10/1/12 - 10:25 am
Lilly
monoclonal antibodies
ramucirumab
lung cancer
Lilly raises 2012 net profit forecast
Reuters
Thu, 08/9/12 - 10:59 am
Lilly
guidance
Why Prolor Biotech Is Rising And Other Attractive Prospects
Seeking Alpha
Fri, 01/20/12 - 09:55 am
Prolor
Abbott Laboratories
Alnylam
GSK
Merck
Pfizer
Lilly
Roche
Lilly’s Zyprexa $4.5 Million Pact With Health Providers Wins Approval
Bloomberg
Thu, 01/12/12 - 02:05 pm
Zyprexa
third party payors
schizophrenia
Lilly
Lilly Has A 20% Downside; Pfizer Safer
Seeking Alpha
Tue, 12/20/11 - 10:27 am
Lilly
Pfizer
solanezumab
Why Bristol-Myers Squibb Could Be Acquired by Lilly or Bayer
BNET Pharma
Wed, 09/21/11 - 12:36 pm
Lilly
Bayer
Bristol-Myers Squibb
M&A